Trevi Therapeutics, Inc. TRVI Proceeds From Warrant Exercises
Proceeds From Warrant Exercises at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromWarrantExercises.
The official record: Trevi Therapeutics, Inc.’s 10-Q, filed August 7, 2025, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s proceeds from warrant exercises.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s proceeds from warrant exercises?
- Trevi Therapeutics, Inc. (TRVI) reported proceeds from warrant exercises of $2.54M in Q2 2025.
- What does proceeds from warrant exercises mean?
- This represents the cash proceeds received by the company when holders of outstanding warrants exercise their right to purchase shares of common stock at a predetermined price. It reflects a source of non-dilutive or secondary capital that occurs when the company's stock price exceeds the exercise price of the warrants. This metric is a key indicator of investor confidence and provides an additional source of liquidity for clinical-stage firms.